Here’s one takeaway from the bribery scandal GlaxoSmithKline is weathering in China: In GlaxoSmithKline’s anguish, there’s solace for the Chinese consumer as the company has begun to lower prices on many of its products.
Related Articles Read More >
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
